Brief: Zoetis Receives Health Canada Approval For Portela(Relfovetmab Injection)
05/12/2025 13:30
Dec 5 (Reuters) - Zoetis Inc ZTS.N: ZOETIS RECEIVES HEALTH CANADA APPROVAL FOR PORTELA™(RELFOVETMAB INJECTION) TO ALLEVIATE PAIN ASSOCIATED WITH OSTEOARTHRITIS IN CATS Source text: ID:nBw1CQjNRa Further company coverage: ZTS.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zoetis
See all newsBrief: Zoetis Receives FDA Approval For Convenia® Rtu For Dogs (Cefovecin Injectable Suspension), Helping More Medium And Large Dogs Access Single-Injection Treatment
Brief: FDA Approves Ready-To-Use Cefovecin Injectable For Treatment Of Certain Skin Infections In Dogs
U.S. RESEARCH ROUNDUP-Masco, Sherwin-Williams, Vulcan Materials
Zoetis gets US FDA emergency use nod for treatment for screwworm in dogs
Brief: FDA Issues Emergency Use Authorization For Simparica Trio To Treat New World Screwworm In Dogs, Puppies